ICU Girişim Sermayesi Yatırım Ortaklığı A.Ş (ICU Venture Capital Trust-ICUGS), whose shares are traded on Borsa Istanbul, is an investment trust subject to the Capital Markets Board of Türkiye legislation.
ICU Venture Capital Trust focuses on innovative, technology-centered, high-development potential enterprises that target sector and market leadership and aims to provide value to all its stakeholders with the investments it makes.
To be a leading alternative investment platform that produces investment opportunities in areas of sustainable development and develops these opportunities within transparent structures so that all investors can participate.
To improve the interests of our stakeholders by creating and developing opportunities and creating value.
Significant Changes in Our Company Since Its Establishment
In 1996, under the leadership of Türkiye Vakıflar Bankası T.A.O., it was established as the first company in its sector with the name 'Vakıf Risk Sermayesi Yatırım Ortaklığı A.Ş.
Initial public offering
In 2004, due to changes in Capital Markets Legislation, the company's name was changed to Vakıf Girişim Sermayesi Yatırım Ortaklığı A.Ş.
In 2009, in line with Türkiye Vakıflar Bankası T.A.O.'s strategic vision, the (A) class shares put up for sale were acquired by the Rhea Group. Consequently, in 2010, the company's name was changed to Rhea Girişim Sermayesi Yatırım Ortaklığı A.Ş.
In 2022, the transfer of the (A) class shares was completed.
Following the developments in 2022, in 2023 the company's name was changed to ICU Girişim Sermayesi Yatırım Ortaklığı A.Ş.
En iyi deneyimleri sunmak için, cihaz bilgilerini saklamak ve/veya bunlara erişmek amacıyla çerezler gibi teknolojiler kullanıyoruz. Bu teknolojilere izin vermek, bu sitedeki tarama davranışı veya benzersiz kimlikler gibi verileri işlememize izin verecektir. Onay vermemek veya onayı geri çekmek, belirli özellikleri ve işlevleri olumsuz etkileyebilir. Sitemizde gezinmeye devam ettiğinizde çerez ve gizlilik politikalarımızı kabul etmiş olacaksınız.